AACR PREVIEW: Early look at new cancer therapies
This article was originally published in Scrip
Executive Summary
The American Association of Cancer Research (AACR) Annual Meeting 2013 from 6 to 10 April in Washington, DC will not generate a lot of headlines for late-stage therapies on the brink of regulatory approvals, but it will deliver early-stage data for technology and mechanisms of action worth watching as they progress in the clinic.